S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01

ZIVO Bioscience Stock Forecast, Price & News

+0.04 (+1.47%)
(As of 01/14/2022 04:00 PM ET)
Today's Range
50-Day Range
52-Week Range
16,738 shs
Average Volume
43,387 shs
Market Capitalization
$26.09 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive ZIVO News and Ratings via Email

Sign-up to receive the latest news and ratings for ZIVO Bioscience and its competitors with MarketBeat's FREE daily newsletter.

ZIVO Bioscience logo

About ZIVO Bioscience

Zivo Bioscience, Inc. engages in the study, development, and commercialization of natural nutritional compounds and bioactive molecules. It offers proprietary algae strain, extracts and supernatants, and bioactive compounds. The company was founded by Howard R. Baer on March 28, 1983 and is headquartered in Keego Harbor, MI.


See More Headlines

Industry, Sector and Symbol

Food & kindred products
Current Symbol
Previous Symbol
Year Founded

Sales & Book Value

Annual Sales
$20 thousand
Book Value
($2.19) per share


Net Income
$-9.11 million
Pretax Margin




Free Float
Market Cap
$26.09 million
Not Optionable

Company Calendar

Last Earnings
Fiscal Year End


Overall MarketRank

2.03 out of 5 stars

Analyst Opinion: 3.5Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 0.0 5 -4 -3 -2 -1 -

ZIVO Bioscience (OTCMKTS:ZIVO) Frequently Asked Questions

Is ZIVO Bioscience a buy right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for ZIVO Bioscience in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ZIVO Bioscience stock.
View analyst ratings for ZIVO Bioscience
or view top-rated stocks.

How has ZIVO Bioscience's stock price been impacted by Coronavirus?

ZIVO Bioscience's stock was trading at $0.14 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, ZIVO shares have increased by 1,878.6% and is now trading at $2.77.
View which stocks have been most impacted by COVID-19

How were ZIVO Bioscience's earnings last quarter?

ZIVO Bioscience, Inc. (OTCMKTS:ZIVO) released its quarterly earnings results on Monday, November, 15th. The biotechnology company reported ($0.21) earnings per share for the quarter.
View ZIVO Bioscience's earnings history

What price target have analysts set for ZIVO?

1 brokerages have issued 1 year price targets for ZIVO Bioscience's stock. Their forecasts range from $9.00 to $9.00. On average, they expect ZIVO Bioscience's share price to reach $9.00 in the next twelve months. This suggests a possible upside of 224.9% from the stock's current price.
View analysts' price targets for ZIVO Bioscience
or view top-rated stocks among Wall Street analysts.

Who are ZIVO Bioscience's key executives?

ZIVO Bioscience's management team includes the following people:
  • Andrew A. Dahl, President, Chief Executive Officer & Director
  • Casey Fowler, Vice President-Operations & Product Development
  • Keith R. Marchiando, Chief Financial Officer, Secretary & Treasurer
  • Amy Elizabeth Steffek, Director-Research & Development
  • William P. Pfund, Vice President-Research & Development

What other stocks do shareholders of ZIVO Bioscience own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ZIVO Bioscience investors own include Nabriva Therapeutics (NBRV), Collegium Pharmaceutical (COLL), Geron (GERN), Johnson & Johnson (JNJ), Unrivaled Brands (TRTC), Abeona Therapeutics (ABEO), ACADIA Pharmaceuticals (ACAD), Alibaba Group (BABA), (CGC) and Chesapeake Energy (CHKAQ).

What is ZIVO Bioscience's stock symbol?

ZIVO Bioscience trades on the OTCMKTS under the ticker symbol "ZIVO."

How do I buy shares of ZIVO Bioscience?

Shares of ZIVO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ZIVO Bioscience's stock price today?

One share of ZIVO stock can currently be purchased for approximately $2.77.

How much money does ZIVO Bioscience make?

ZIVO Bioscience has a market capitalization of $26.09 million and generates $20 thousand in revenue each year. The biotechnology company earns $-9.11 million in net income (profit) each year or ($1.29) on an earnings per share basis.

How many employees does ZIVO Bioscience have?

ZIVO Bioscience employs 8 workers across the globe.

What is ZIVO Bioscience's official website?

The official website for ZIVO Bioscience is www.zivobioscience.com.

Where are ZIVO Bioscience's headquarters?

ZIVO Bioscience is headquartered at 2804 ORCHARD LAKE ROAD SUITE 202, KEEGO HARBOR MI, 48320.

How can I contact ZIVO Bioscience?

ZIVO Bioscience's mailing address is 2804 ORCHARD LAKE ROAD SUITE 202, KEEGO HARBOR MI, 48320. The biotechnology company can be reached via phone at (248) 452-9866 or via email at [email protected].

This page was last updated on 1/16/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.